Patents by Inventor John W. Poore
John W. Poore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20140114387Abstract: An implantable therapy lead includes a tubular body, an obturator, and a helical anchor electrode. The obturator is displaceably supported on a distal end of the tubular body between a recessed position and an extended position. When the obturator is in the extended position, the extreme distal tip of the tissue penetrating point of the helical anchor electrode contacts an outer surface of the obturator in a manner that prevents the extreme distal tip from being capable of tissue penetration significant enough to allow the helical anchor electrode to be screwed into the heart tissue. When the obturator is in the recessed position, the extreme distal tip no longer contacts the outer surface of the obturator and the extreme distal tip is positioned relative to the outer surface of the obturator so as to allow the extreme distal tip to penetrate the heart tissue.Type: ApplicationFiled: October 18, 2012Publication date: April 24, 2014Applicant: PACESETTER, INC.Inventors: John W. Poore, Gene A. Bornzin, Zoltan Somogyi, Steven R. Conger
-
Patent number: 8700181Abstract: A leadless intra-cardiac medical device (LIMD) configured to be implanted entirely within a heart of a patient includes a housing configured to be securely attached to an interior wall portion of a chamber of the heart, and a stabilizing intra-cardiac (IC) device extension connected to the housing. The stabilizing IC device extension may include a stabilizer arm, and/or an appendage arm, or an elongated body or a loop member configured to be passively secured within the heart.Type: GrantFiled: January 17, 2012Date of Patent: April 15, 2014Assignee: Pacesetter, Inc.Inventors: Gene A. Bornzin, Xiaoyi Min, John W. Poore, Zoltan Somogyi, Didier Theret
-
Patent number: 8670842Abstract: An intra-cardiac implantable medical device (IIMD) system may include a housing and an intra-cardiac (IC) device extension. The housing may be configured to be implanted entirely within a local chamber of the heart. The housing includes a base configured to be secured to the local chamber. The IC device extension may include a proximal end, a distal end, and an extension body extending there between. The proximal end may be coupled to the housing and configured to be located in the local chamber. The extension body may include an IE orientation segment connected to a chamber transition segment that is sufficient in length to extend from the local chamber into an adjacent chamber. The IE orientation segment is configured to be lodged within the adjacent chamber in order to stabilize the system within heart.Type: GrantFiled: December 14, 2012Date of Patent: March 11, 2014Assignee: Pacesetter, Inc.Inventors: Gene A. Bornzin, John W. Poore, Zoltan Somogyi, Xiaoyi Min, Didier Theret, Elaine Karaelias
-
Patent number: 8647675Abstract: Disclosed herein is an implantable medical device including an antimicrobial layer. The antimicrobial layer may include a first distinct size of silver nanoparticles, a second distinct size of silver nanoparticles, and a third distinct size of silver nanoparticles. The antimicrobial layer extends over a surface of the implantable medical device, and, in some instances, the surface of the implantable medical device may serve as a substrate on which the antimicrobial layer is deposited.Type: GrantFiled: March 8, 2012Date of Patent: February 11, 2014Assignee: Pacesetter, Inc.Inventors: Yelena Nabutovsky, Gene A. Bornzin, Annapurna Karicherla, Nirav Dalal, Prashant Dinesh, Richard Samade, John W. Poore
-
Patent number: 8634912Abstract: A leadless intra-cardiac medical device includes a housing that is configured to be implanted entirely within a single local chamber of the heart. A first electrode is provided on the housing at a first position such that when the housing is implanted in the local chamber, the first electrode engages the local wall tissue at a local activation site within the conduction network of the local chamber. An intra-cardiac extension is coupled to the housing and configured to extend from the local chamber into an adjacent chamber of the heart. A stabilization arm of the intra-cardiac extension engages the adjacent chamber. A second electrode on the intra-cardiac extension engages distal wall tissue at a distal activation site within the conduction network of the adjacent chamber.Type: GrantFiled: January 17, 2012Date of Patent: January 21, 2014Assignee: Pacesetter, Inc.Inventors: Gene A. Bornzin, Gabriel A. Mouchawar, Xiaoyi Min, John W. Poore, Edward Karst, Richard Samade, Zoltan Somogyi, Didier Theret
-
Publication number: 20140018818Abstract: A system for implanting an implantable medical device (IMD) within a patient may include a main handle assembly having proximal and distal ends, a device-connection control handle connected to the proximal end of the main handle assembly, an introducer connected to the distal end of the main handle assembly, and a connection tool extending from the introducer. The connection tool may include a device-engaging member configured to change at least one of shape or orientation to selectively connect to and disconnect from the IMD. The device-connection control handle may be operatively connected to the device-engaging member and the device-connection control handle may be configured to manipulate the device-engaging member between connected and disconnected states by changing the at least one of the shape or orientation.Type: ApplicationFiled: July 12, 2012Publication date: January 16, 2014Applicant: PACESETTER, INC.Inventors: Zoltan Somogyi, Edward Karst, Gene A. Bornzin, John W. Poore, Richard Samade, Didier Theret
-
Patent number: 8626293Abstract: A method for detecting potential failures by a lead of an implantable medical device is provided. The method includes sensing a first signal over a first channel between a first combination of electrodes on the lead and sensing a second signal from a second channel between a second combination of electrodes on the lead. The method determines whether at least one of the first and second signals is representative of a potential failure in the lead and identifies a failure and the electrode associated with the failure based on which of the first and second sensed signals is representative of the potential failure. Optionally, when the first and second sensed signals are both representative of the potential failure, the method further includes determining whether the first and second sensed signals are correlated with one another. When the first and second sensed signals are correlated, the method declares an electrode common to both of the first and second combinations to be associated with the failure.Type: GrantFiled: February 4, 2013Date of Patent: January 7, 2014Assignee: Pacesetter, Inc.Inventors: Gene A. Bornzin, John W. Poore, Richard Williamson, Gabriel A. Mouchawar, Eric S. Fain
-
Publication number: 20140005605Abstract: A coating on at least a portion of an implantable medical device includes a polymer and an agent that inhibits the formation of biofilms. The agent inhibiting the formation of a biofilm includes a quorum sensing inhibitor (QSI), a biofilm dispersing agent (BDA) or both. The agent may also be delivered via an actuator associated with the implantable medical device.Type: ApplicationFiled: June 28, 2012Publication date: January 2, 2014Applicant: PACESETTER, INC.Inventors: Richard Samade, Prashant Dinesh, Yelena Nabutovsky, Gene A. Bornzin, John W. Poore, Annapurna Karicherla, Nirav Dalal
-
Publication number: 20130345770Abstract: A leadless implantable medical device (LIMD) includes a housing formed from a battery and an end cap. A proximal end of the end cap forms an LIMD proximal end and a distal end of the battery case forms an LIMD distal end. A non-conductive coupler mechanically secures a terminal end of the battery case to a mating end of the end cap, while maintaining the battery case and end cap electrically separated. A first electrode projects from the proximal end of the end cap. An intra-cardiac (IC) device extension projects from the distal end of the battery case. The extension includes a second electrode that is electrically connected to the battery case. The second electrode is located remote from the LIMD distal end. An electronics module is located within an internal cavity of the end cap and communicates with the first and second electrodes.Type: ApplicationFiled: June 21, 2012Publication date: December 26, 2013Applicant: PACESETTER, INC.Inventors: Ali Dianaty, Gabriel A. Mouchawar, Gene A. Bornzin, John W. Poore, Xiaoyi Min, Zoltan Somogyi, Richard Williamson
-
Publication number: 20130325081Abstract: A leadless intra-cardiac medical device senses cardiac activity from multiple chambers and applies cardiac stimulation to at least one cardiac chamber and/or generates a cardiac diagnostic indication. The leadless device may be implanted in a local cardiac chamber (e.g., the right ventricle) and detect near-field signals from that chamber as well as far-field signals from an adjacent chamber (e.g., the right atrium).Type: ApplicationFiled: May 31, 2012Publication date: December 5, 2013Applicant: PACESETTER, INC.Inventors: Edward Karst, Richard Samade, Gene A. Bornzin, John W. Poore, Zoltan Somogyi, Didier Theret
-
Publication number: 20130296661Abstract: An implantable physiologic sensor assembly is configured to be implanted within a patient. The assembly includes a module that houses an internal operative chamber, and a flexible pressure-detecting member connected to the module. The module and the pressure-detecting member are separated before implantation into the patient. At least a first end of the pressure-detecting member is configured to be inserted into an artery of the patient and a second end of the pressure-detecting member is connected to the module. The module is configured to be subcutaneously positioned within the patient.Type: ApplicationFiled: May 4, 2012Publication date: November 7, 2013Applicant: PACESETTER, INC.Inventors: Gene A. Bornzin, John W. Poore, Zoltan Somogyi
-
Patent number: 8574737Abstract: A bioelectric battery may be used to power implantable devices. The bioelectric battery may have an anode electrode and a cathode electrode separated by an insulating member comprising a tube having a first end and a second end, wherein said anode is inserted into said first end of said tube and said cathode surrounds said tube such that the tube provides a support for the cathode electrode. The bioelectric battery may also have a membrane surrounding the cathode to reduce tissue encapsulation. Alternatively, an anode electrode, a cathode electrode surrounding the cathode electrode, a permeable membrane surrounding the cathode electrode. An electrolyte is disposed within the permeable membrane and a mesh surrounds the permeable membrane. In an alternative embodiment, a pacemaker housing acts as a cathode electrode for a bioelectric battery and an anode electrode is attached to the housing with an insulative adhesive.Type: GrantFiled: January 31, 2011Date of Patent: November 5, 2013Assignee: Pacesetter, Inc.Inventors: Naixiong Jiang, Gene A. Bornzin, John W. Poore, Sheldon Williams, Weiqun Yang, Taraneh Ghaffari Farazi
-
Patent number: 8571683Abstract: A high Q self-resonant inductor and method for manufacturing the same is disclosed herein for use in an implantable medical lead. The method of manufacture includes depositing a first conductive material over an elongated ceramic member and removing portions of the conductive material to leave a continuous helical metallic pattern on an elongated ceramic structure. The helical metallic pattern has a first terminal end located at a proximal end of the elongated ceramic member and a second terminal end located at a distal end of the ceramic member. The method also includes covering the helical metallic pattern with a ceramic material to form a first ceramic layer and forming vias in the ceramic material. At least one electrode is coupled to the helical metallic pattern through the vias in the ceramic material.Type: GrantFiled: September 10, 2009Date of Patent: October 29, 2013Assignee: Pacesetter, Inc.Inventor: John W. Poore
-
Publication number: 20130238085Abstract: Disclosed herein is an implantable medical device including an antimicrobial layer. The antimicrobial layer may include a first distinct size of silver nanoparticles, a second distinct size of silver nanoparticles, and a third distinct size of silver nanoparticles. The antimicrobial layer extends over a surface of the implantable medical device, and, in some instances, the surface of the implantable medical device may serve as a substrate on which the antimicrobial layer is deposited.Type: ApplicationFiled: March 8, 2012Publication date: September 12, 2013Applicant: PACESETTER, INC.Inventors: Yelena Nabutovsky, Gene A. Bornzin, Annapurna Karicherla, Nirav Dalal, Prashant Dinesh, Richard Samade, John W. Poore
-
Publication number: 20130238056Abstract: A communication circuit of an implantable device is coupled to a power source (e.g., including a battery) upon receipt of a radiofrequency (RF) signal at the implantable device. A circuit that controls whether the communication circuit is to be coupled to the power source obtains its power from the received RF signal. Thus, the implantable device is able to perform RF signal monitoring (e.g., RF “sniffing”) without using battery power. Battery power is then used for subsequent communication operations after it has been determined that the implantable device is receiving RF signals (e.g., from a verified external device).Type: ApplicationFiled: March 6, 2012Publication date: September 12, 2013Applicant: PACESETTER, INC.Inventors: John W. Poore, Gene A. Bornzin
-
Publication number: 20130193947Abstract: A high voltage resonant step-up convertor converts a lower voltage signal to a higher voltage signal. The converter may be used, for example, to supply power via electromagnetic coupling to an implantable medical device. In some embodiments, a power converter comprises a driver circuit and a resonant circuit. The resonant circuit generates a high voltage output signal at a selected frequency. The driver circuit is controlled by a low voltage signal and periodically generates a higher frequency signal (e.g., approximately twice the selected frequency) to drive the resonant circuit. In some embodiments, the driver circuit comprises another resonant circuit and a switching circuit. The switching circuit periodically pumps current to the other resonant circuit and isolates the two resonant circuits. The other resonant circuit periodically pumps current to the output resonant circuit.Type: ApplicationFiled: January 30, 2012Publication date: August 1, 2013Applicant: PACESETTER, INC.Inventors: John W. Poore, Gene A. Bornzin
-
Publication number: 20130138006Abstract: A leadless intra-cardiac medical device (LIMD) includes multiple electrodes that allow for stimulation and sensing of the right ventricle (RV) and sensing of the right atrium (RA), even though it is entirely located in the RV. The LIMD includes a housing having a proximal end configured to engage local tissue in the local chamber and electrodes located at multiple locations along the housing. Sensing circuitry is configured to define a far field (FF) channel between a first combination of the electrodes to sense FF signals occurring in the adjacent chamber. The sensing circuitry is configured to define a near field (NF) channel between a second combination of the electrodes to sense NF signals occurring in the local chamber. A controller is configured to analyze the NF and FF signals to determine whether the NF and FF signals collectively indicate that a validated event of interest occurred in the adjacent chamber.Type: ApplicationFiled: May 31, 2012Publication date: May 30, 2013Applicant: PACESETTER, INC.Inventors: Gene A. Bornzin, Xiaoyi Min, John W. Poore, Zoltan Somogyi
-
Patent number: 8442620Abstract: A lead implantation system with an introducer, a lead configured to engage with the introducer such that the introducer can convey the lead to a desired internal target location, and at least one sensor. The sensor is adapted to generate an indicator of desired engagement of the system with the desired target tissue location prior to engagement of the lead with the target tissue. Also a method of implanting an implantable patient lead including advancing a lead implantation assembly towards a desired target location along an introduction axis and monitoring at least one indicator of lead implantation assembly position along the lead introduction axis. At least one indicator can be generated by the lead implantation assembly. Advancing of the lead introduction assembly can be halted when the monitoring indicates contact with the desired target tissue. The patient lead can then be advanced towards the target tissue and fixed to the target tissue.Type: GrantFiled: October 1, 2008Date of Patent: May 14, 2013Assignee: Pacesetter, Inc.Inventors: Enzo Silipo, Kyungmoo Ryu, Gene A. Bornzin, John W. Poore, Keith Victorine, Zoltan Somogyi, Nalin Perera
-
Publication number: 20130116738Abstract: A leadless intra-cardiac medical device (LIMD) includes a housing configured to be implanted entirely within a single local chamber of the heart.Type: ApplicationFiled: January 17, 2012Publication date: May 9, 2013Applicant: PACESETTER, INC.Inventors: Richard Samade, Edward Karst, Gene A. Bornzin, John W. Poore, Zoltan Somogyi, Didier Theret, Nirav Dalal
-
Publication number: 20130116529Abstract: A leadless intra-cardiac medical device is configured to be implanted entirely within a heart of a patient. The device includes an intra-cardiac extension and a housing. The intra-cardiac extension includes a loop body having at least one loop segment retaining at least one coil group that is configured to one or both of receive and transmit radio frequency (RF) energy, wherein the loop body is configured to extend into a first chamber of the heart. The housing is in electrical communication within the loop body, and includes a transceiver, control logic and an energy source. The housing is configured to be securely attached to an interior wall portion of a second chamber of the heart, wherein the transceiver is configured to communicate with an external device through the RF energy.Type: ApplicationFiled: January 17, 2012Publication date: May 9, 2013Applicant: PACESETTER, INC.Inventors: Xiaoyi Min, John W. Poore, Gene A. Bornzin